News 4/25/25
Top News
Eli Lilly sues four telehealth startups — Mochi Health, Willow Health, Fella & Delilah Health, and Henry Meds — for selling compounded versions of its $1,000-per-month GLP-1 weight loss drug Zepbound.
The FDA…
Tag: weight loss drug
Build My Health Webinar Highlights New Age for Physician Practices with Rise of GLP1 Drugs for Obesity – MedCity News
The healthcare industry has embraced GLP1 drugs as an effective way to lose weight. But the popularity of these drugs has made them tough to obtain. In a webinar last week, CEO and Co-founder…
Continue Reading
Prescribing Trends Surge: Wegovy & Ozempic Gain Popularity
What You Should Know: – Prescriptions for the popular weight loss drug Wegovy showed a six-fold increase between December 2022 and June 2023, according to a recent analysis of prescribing trends by DrFirst. –…
Continue Reading
Omada Launches Program To Support Patients on GLP-1s – MedCity News
Demand for GLP-1 drugs — which help patients feel fuller for longer and lose weight — is skyrocketing. In response, virtual healthcare provider Omada Health is launching a program that offers lifestyle and behavior…
Continue Reading